Chemo Drug May Buy Time for Those With Bile Duct Cancer
THURSDAY, May 18, 2017 -- The chemotherapy drug Xeloda may prolong survival in those struck by a type of digestive system cancer, a new study finds.
People with bile duct cancer who received the medication lived for an average of about 17 months...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Bile | Bile Duct Cancer | Cancer | Cancer & Oncology | Chemotherapy | Cholangiocarcinoma | General Medicine | Study | Xeloda